Meeting Report: Sustaining and strengthening HIV vaccine R&D in Europe

The Global HIV Vaccine Enterprise (the Enterprise) meeting in Ghent, Belgium, provided an opportunity to engage as a region on critical issues, including political and research commitments in Europe, with the aim of ensuring that HIV vaccine R&D remains a key priority in a challenging and changing global health landscape.

Viewpoint: The complex challenges of HIV vaccine development

In this viewpoint published in The Lancet, key stakeholders look into the challenges of developing an HIV vaccine from development to marketing.

ICASA 2019 Road Map of HIV Vaccine Research and Development

The Global HIV Vaccine Enterprise is looking forward to the 20th International Conference on AIDS and STIs in Africa (ICASA 2019) taking place on 2-7th December 2019 in Kigali, Rwanda.

ICASA represents the largest AIDS conference in Africa with over 10 000 delegates expected. The conference theme for 2019 is “AIDS free Africa – Innovation, Community and Political Leadership”. This is a tremendous opportunity for the international community to join efforts in committing to achieving an AIDS-free Africa.